Pregnancy Category C: Animal reproduction studies have shown adverse effects on the fetus and there are no adequate and well controlled studies in humans. Cilnidipine may be used in pregnancy only if the potential benefits justify the risk.
It is not known if Cilnidipine is secreted in human breast milk. A decision should be made to discontinue lactation, if the nursing mother needs to be prescribed Cilnidipine.